Acorda Shareholders Invited to Virtual Q&A with CEO Ron Cohen, M.D.
21.10.2022 - Acorda Therapeutics, Inc. (Nasdaq: ACOR) will hold a virtual, video Q&A with its CEO, Ron Cohen, M.D., on Friday, October 28 at 1:00pm ET, 10:00am PT. The call will review the items on the ballot for Acorda’s Special Meeting of Shareholders on ... Seite 1